Nanjing Chemical Reagent Co., LtdProduced by (referred to as "Southern Trial")Pharmaceutical excipient zinc sulfateRegistration has been completed and published, with registration number F20250000653 (packaging 500g/bottle, 25kg/bag); Without changing the material of the inner packaging, packaging specifications can be added according to customer needs. This marks another important breakthrough for Nan Shi in the field of pharmaceutical excipients, and also provides domestic pharmaceutical companies with a new choice of compliant, stable, and high-quality domestic excipients.

Zinc sulfate pharmaceutical excipientWidely used in oral solid preparations, nutritional supplements, ophthalmic drugs, and topical preparations, it has multiple functions such as regulating trace element balance, promoting wound healing, and assisting immune regulation. Its quality directly affects the safety and effectiveness of the formulation, and the control requirements for impurities such as heavy metals, arsenic salts, and chlorides are extremely strict. The analytical reagent drop analysis method is used to determine copper and chlorate. Serum protein test to determine the sulfur content of steel and slag. Coal dyes, disinfectants, and various culture media are prepared for haploid breeding. In plant cell culture, zinc is used as a source to support membrane stability and gene regulation.

Nanjing reagentPharmaceutical excipient zinc sulfateQuality control throughout the entire process, from raw material screening to finished product inspection, to ensure consistency between batches; The CDE platform has officially registered and announced, supporting customers to simplify registration information and accelerate the process of drug listing; Stable production capacity guarantee to meet the bulk procurement and long-term cooperation needs of large customers.